Next generation of Concentriq accelerates enterprise adoption of AI-enabled digital pathology. PHILADELPHIA--(BUSINESS WIRE)--Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next generation of...

End-to-end transformation will enable groundbreaking biomedical research, advance precision medicine initiatives, and improve routine diagnosis PHILADELPHIA – October 20, 2020 – Proscia®, a leading provider of digital and computational...

The FDA has issued guidance aimed at expanding the use of remote digital pathology devices during the COVID-19 pandemic. In response to the FDA’s guidance, Proscia announced today that we are now offering our Concentriq Dx digital...

Release coincides with newly-formed collaboration to address growing infrastructure requirements for deploying digital pathology system Philadelphia – Proscia, a leading provider of digital pathology software, announces the Fall 2019 release...

Recognized for disrupting 150-year-old practice of pathology with artificial intelligence to improve cancer patient outcomes Proscia, a leading provider of digital pathology software, has been named to the CNBC Upstart 100, an exclusive...

U.S. Patent No. 10,346,980 addresses techniques critical to the advancement of digital pathology PHILADELPHIA (PRWEB) SEPTEMBER 24, 2019 -- Proscia, a leading provider of digital pathology software, has been granted U.S. Patent No. 10,346,980...